Nationally Recognized Bladder Cancer Surgeon Dr. Robert Svatek Visits DHR Health

Translate to Spanish or other 102 languages!

DHR Health Urology Insitute physicians with Dr. Svatek during visit.  Left to Right: Dr. Henry Ruiz, Medical Director at DHR Health Urology Insitute, Dr. Robert Svatek, Chair of Urology at UTHSCSA, Dr. Gustavo Villegas, Dr. Maria Rodriguez, and Dr. Gaudencio Olguin.

Mega Doctor News

- Advertisement -

Edinburg, TX – Dr. Robert Svatek, the Chair of Urology at UT Science Center at San Antonio (UTHSCSA) and one of the top five highest volume bladder cancer surgeons in the United States, visited DHR Health and DHR Health Institute for Research and Development to discuss collaborative efforts that will continue to enhance the ongoing partnership of advancing clinical care and research benefiting Rio Grande Valley residents.

“Dr. Robert Svatek is a nationally recognized urologic surgeon-scientist with clinical expertise in early and late phase clinical trials and urologic cancers” said Dr. Henry Ruiz, Medical Director at DHR Health Urology Institute. “Many areas of common clinical and research interests were discussed and we look forward to continuing to work with Dr. Svatek and his team at UTHSCSA to provide the highest level of care to members of our community”.

DHR Health has endowed a Distinguished Chair in Urology at UTHSCSA. The primary objective of this endowment is to create a closer and more productive partnership between the institutions, which would benefit the Rio Grande Valley community. American Cancer Society has projected that over 248,000 patients will be diagnosed with prostate cancer in 2021 and more than 34,000 will have a fatal outcome. In addition, according to the Prostate Cancer Foundation, prostate cancer is the most commonly diagnosed cancer among Hispanic/Latino men in the United States.  

- Advertisement -

“Bladder cancer is also a serious clinical challenge in the Rio Grande Valley” said Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development.   “American Cancer Society has predicted that more than 83,700 patients will be diagnosed with bladder cancer in 2021 with a very high incidence (>20%) of fatal outcome.  Given Dr. Svatek’s interest in developing innovative strategies to treat bladder cancer, our goal is to work closely with his team at UTHSCSA to partner in these innovative clinical studies”.

For more information on research studies and collaborations, please contact Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development at (956) 362-2387 or visit www.dhrresearch.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Think Pink Campaign Aims to Help RGV Women Detect Breast Cancer Early

Every year, thousands of women receive a breast cancer diagnosis. As breast cancer rates continue to climb across the United States, health experts are urging women not to delay routine screenings that could save their lives

DHR Health Launches Nurse-Family Partnership Program

Since 2012, DHR Health Women’s Hospital has been offering the Nurse-Family Partnership program, a free community program designed for first-time moms who meet income eligibility requirements.

Physicians Sound Alarm Over AI Medical Advice

Patients are increasingly engaging with artificial intelligence (AI) sources for health information – without physician input or guidance – leaving some physicians concerned about the quality of the information. As a result, some Texas physicians ask patients about their use of AI for medical information.

STHS to Host Annual Think Pink Parade to Drive Breast Cancer Awareness, Oct. 3rd

Breast cancer remains one of the most commonly diagnosed cancers among women in the United States and is a leading cause of cancer-related deaths.
- Advertisement -